MedTrace Logo

Photo Biomodulation Therapy for Alveolar Osteitis Recovery in Oral Contraceptive Users

NCT06865508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-03-10

No results posted yet for this study

Summary

does laser effect on alveolar osteitis recovery in oral contraceptive users ?

Conditions

  • Alveolar Osteitis

Interventions

DEVICE

Laser therapy

Laser therapy was administered using a low-level laser device with the following parameters: \[ wavelength 980 nm810, power 500mw, and duration 90 seconds (30second for each 3 sides\].

DEVICE

zinc oxide eugenol dressing.

zinc oxide eugenol dressing.

Sponsors & Collaborators

  • Badr University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-11-01
Completion
2024-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06865508 on ClinicalTrials.gov